Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women
1 other identifier
interventional
136
1 country
1
Brief Summary
Excessive weight gain during pregnancy, particularly in overweight and obese women, predisposes to adverse perinatal outcomes and has long term effects on maternal and neonatal health. With an inverse relationship between socioeconomic status and obesity, significant health disparities exist between obese and normal weight women. The Institute of Medicine (IOM) recently revised its gestational weight gain recommendations, targeted to pregravid body mass index (BMI), to minimize pregnancy complications. However, these recommendations are based on cross sectional observational studies and neither the ideal method to achieve weight gain goals nor whether perinatal outcome is optimized with active management of weight gain is known. The investigators propose to investigate a behavioral incentive-based intervention to improve compliance with IOM weight gain recommendations during pregnancy in low-income overweight and obese women. The investigators will evaluate if 1) gestational weight gain can be reliably targeted to the IOM recommendations and 2) active weight gain management during pregnancy improves perinatal outcomes. Two study groups will be compared in a prospective randomized trial; 1) those receiving standard obstetrical care and 2) those receiving behavioral weight management counseling plus financial incentives for achieving weight gain goals. The main outcome measure will be the percentage of women gaining within the IOM recommendations based on prepregnancy BMI. Secondary outcomes evaluated will include fetal growth and body composition changes, birth weight and the rate of cesarean delivery. The investigators hypothesize that 1) the behavioral intervention with incentives will result in greater compliance to IOM guidelines for gestational weight gain than standard care and 2) targeting weight gain to the IOM guidelines will lead to a reduction in the rates of fetal macrosomia and cesarean delivery. Finally, cost effectiveness of treatment conditions will be examined. This intervention, if efficacious and cost-effective, has the potential to improve compliance with gestational weight gain guidelines, optimize perinatal outcomes, and reduce health disparities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 3, 2014
CompletedFirst Posted
Study publicly available on registry
September 8, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2017
CompletedOctober 15, 2018
October 1, 2018
3.5 years
September 3, 2014
October 10, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gestational weight gain within the Institute of Medicine guidelines
Total gestational weight gain at time of last prenatal visit. For participants in the intervention arm, gestational weight gain at 2 week intervals will also be assessed.
At time of delivery
Secondary Outcomes (2)
Cesarean delivery rate
Time of delivery
Fetal macrosomia
At delivery
Other Outcomes (1)
Cost of intervention
Intake to 6 weeks postpartum
Study Arms (2)
Behavioral, incentives
EXPERIMENTALParticipants receive behavioral intervention and financial incentives for meeting gestational weight gain goals
Standard care
NO INTERVENTIONParticipants receive standard obstetrical care from their provider
Interventions
Participants receive a behavioral intervention and financial incentives for meeting gestational weight gain goals.
Eligibility Criteria
You may qualify if:
- ≥18 years of age and ≤ 45 years of age
- ≤16 weeks gestation
- BMI ≥25
- Ultrasound documented viable singleton intrauterine pregnancy
- English speaking
- Planning to deliver at Fletcher Allen Health Care
- Willing to be randomized to one of the study groups
- Written informed consent
You may not qualify if:
- Major fetal congenital or chromosomal anomaly
- Women with a restricted diet (i.e., celiac disease, prior bariatric surgery, Phenylketonuria, or other metabolic disorder)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Vermont
Burlington, Vermont, 05401, United States
Related Publications (1)
Phillips JK, Skelly JM, Roberts LM, Bernstein IM, Higgins ST. Combined financial incentives and behavioral weight management to enhance adherence with gestational weight gain guidelines: a randomized controlled trial. Am J Obstet Gynecol MFM. 2019 Mar;1(1):42-49. doi: 10.1016/j.ajogmf.2019.02.002. Epub 2019 Mar 5.
PMID: 33319756DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Project Director
Study Record Dates
First Submitted
September 3, 2014
First Posted
September 8, 2014
Study Start
March 1, 2014
Primary Completion
August 28, 2017
Study Completion
August 28, 2017
Last Updated
October 15, 2018
Record last verified: 2018-10